Preclinical efficacy and safety evaluation of interleukin-6-knockdown CAR-T cells targeting at CD19

BACKGROUND: ssCART-19 cells with shRNA-IL-6 gene knockdown were subjected to a comprehensive safety evaluation, including efficacy, toxicity and biodistribution studies in NSG (Prkdc(scid)IL2rg(tm1)/Bcgen) mice. METHODS: NSG mice were administered Raji-Luc and then singly dosed with ssCART-19 cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Hairuo, Huo, Guitao, Hou, Tiantian, Qu, Zhe, Sun, Juanjuan, Yu, Zhou, Kang, Liqing, Wang, Manhong, Lou, Xiaoyan, Yu, Lei, Huo, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743728/
https://www.ncbi.nlm.nih.gov/pubmed/35071407
http://dx.doi.org/10.21037/atm-21-3372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743728/
https://www.ncbi.nlm.nih.gov/pubmed/35071407
http://dx.doi.org/10.21037/atm-21-3372

Ejemplares similares